CD83 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "CD83" in English language version.

Last modified: 03:03:06, 17 August 2026 (UTC)

Ref.Un. Ref.Website

Global rank English rank

6843nih.gov

5^th place

4026doi.org

2^nd place

62ensembl.org

630^th place

326^th place

22semanticscholar.org

15^th place

8^th place

11mallia.com

low place

11patents.google.com

1,154^th place

606^th place

doi.org (Global: 2^nd place; English: 2^nd place)

Prechtel AT, Steinkasserer A (May 2007). "CD83: an update on functions and prospects of the maturation marker of dendritic cells". Archives of Dermatological Research. 299 (2): 59–69. doi:10.1007/s00403-007-0743-z. PMID 17334966.
Grosche L, Knippertz I, König C, Royzman D, Wild AB, Zinser E, et al. (2020). "The CD83 Molecule - An Important Immune Checkpoint". Frontiers in Immunology. 11 721. doi:10.3389/fimmu.2020.00721. PMC 7181454. PMID 32362900.
Berchtold S, Jones T, Mühl-Zürbes P, Sheer D, Schuler G, Steinkasserer A (March 1999). "The human dendritic cell marker CD83 maps to chromosome 6p23". Annals of Human Genetics. 63 (Pt 2): 181–183. doi:10.1046/j.1469-1809.1999.6320181.x. PMID 10738529. S2CID 25338621.
Horvatinovich JM, Grogan EW, Norris M, Steinkasserer A, Lemos H, Mellor AL, et al. (March 2017). "Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14⁺ Monocytes". Journal of Immunology. 198 (6). Baltimore: 2286–2301. doi:10.4049/jimmunol.1600802. PMC 5340622. PMID 28193829.
Heilingloh CS, Klingl S, Egerer-Sieber C, Schmid B, Weiler S, Mühl-Zürbes P, et al. (April 2017). "Crystal Structure of the Extracellular Domain of the Human Dendritic Cell Surface Marker CD83". Journal of Molecular Biology. 429 (8): 1227–1243. doi:10.1016/j.jmb.2017.03.009. PMID 28315353.
Twist CJ, Beier DR, Disteche CM, Edelhoff S, Tedder TF (1998). "The mouse Cd83 gene: structure, domain organization, and chromosome localization". Immunogenetics. 48 (6): 383–393. doi:10.1007/s002510050449. PMID 9799334. S2CID 19869850.
Stein MF, Lang S, Winkler TH, Deinzer A, Erber S, Nettelbeck DM, et al. (April 2013). "Multiple interferon regulatory factor and NF-κB sites cooperate in mediating cell-type- and maturation-specific activation of the human CD83 promoter in dendritic cells". Molecular and Cellular Biology. 33 (7): 1331–1344. doi:10.1128/MCB.01051-12. PMC 3624272. PMID 23339870.
Michalski J, Deinzer A, Stich L, Zinser E, Steinkasserer A, Knippertz I (July 2020). "Quercetin induces an immunoregulatory phenotype in maturing human dendritic cells". Immunobiology. 225 (4) 151929. doi:10.1016/j.imbio.2020.151929. PMID 32115260.
Breloer M, Fleischer B (April 2008). "CD83 regulates lymphocyte maturation, activation and homeostasis". Trends in Immunology. 29 (4): 186–194. doi:10.1016/j.it.2008.01.009. PMID 18329338.
von Rohrscheidt J, Petrozziello E, Nedjic J, Federle C, Krzyzak L, Ploegh HL, et al. (August 2016). "Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83". The Journal of Experimental Medicine. 213 (9): 1685–1694. doi:10.1084/jem.20160316. PMC 4995086. PMID 27503071.
Cramer SO, Trumpfheller C, Mehlhoop U, Moré S, Fleischer B, von Bonin A (September 2000). "Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells". International Immunology. 12 (9): 1347–1351. doi:10.1093/intimm/12.9.1347. PMID 10967030.
Lechmann M, Krooshoop DJ, Dudziak D, Kremmer E, Kuhnt C, Figdor CG, et al. (December 2001). "The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells". The Journal of Experimental Medicine. 194 (12): 1813–1821. doi:10.1084/jem.194.12.1813. PMC 2193561. PMID 11748282.
Hirano N, Butler MO, Xia Z, Ansén S, von Bergwelt-Baildon MS, Neuberg D, et al. (February 2006). "Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity". Blood. 107 (4): 1528–1536. doi:10.1182/blood-2005-05-2073. PMC 1895420. PMID 16239433.
Bates JM, Flanagan K, Mo L, Ota N, Ding J, Ho S, et al. (March 2015). "Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis". Mucosal Immunology. 8 (2): 414–428. doi:10.1038/mi.2014.79. PMC 4326976. PMID 25204675.
Sinner P, Peckert-Maier K, Mohammadian H, Kuhnt C, Draßner C, Panagiotakopoulou V, et al. (August 2023). "Microglial expression of CD83 governs cellular activation and restrains neuroinflammation in experimental autoimmune encephalomyelitis". Nature Communications. 14 (1) 4601. doi:10.1038/s41467-023-40370-2. PMC 10393859. PMID 37528070.
Wu YJ, Song YN, Geng XR, Ma F, Mo LH, Zhang XW, et al. (2020). "Soluble CD83 alleviates experimental allergic rhinitis through modulating antigen-specific Th2 cell property". International Journal of Biological Sciences. 16 (2): 216–227. doi:10.7150/ijbs.38722. PMC 6949156. PMID 31929750.
Fujimoto Y, Tu L, Miller AS, Bock C, Fujimoto M, Doyle C, et al. (March 2002). "CD83 expression influences CD4+ T cell development in the thymus". Cell. 108 (6): 755–767. doi:10.1016/S0092-8674(02)00673-6. PMID 11955430.
Doebbeler M, Koenig C, Krzyzak L, Seitz C, Wild A, Ulas T, et al. (June 2018). "CD83 expression is essential for Treg cell differentiation and stability". JCI Insight. 3 (11) e99712. doi:10.1172/jci.insight.99712. PMC 6124443. PMID 29875316.
Maitra U, Davis S, Reilly CM, Li L (May 2009). "Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1". Journal of Immunology. 182 (9). Baltimore: 5763–5769. doi:10.4049/jimmunol.0900124. PMC 4773027. PMID 19380824.
Wild AB, Krzyzak L, Peckert K, Stich L, Kuhnt C, Butterhof A, et al. (October 2019). "CD83 orchestrates immunity toward self and non-self in dendritic cells". JCI Insight. 4 (20) e126246. doi:10.1172/jci.insight.126246. PMC 6824314. PMID 31527313.
Kretschmer B, Kühl S, Fleischer B, Breloer M (May 2011). "Activated T cells induce rapid CD83 expression on B cells by engagement of CD40". Immunology Letters. 136 (2): 221–227. doi:10.1016/j.imlet.2011.01.013. PMID 21277328.
Krzyzak L, Seitz C, Urbat A, Hutzler S, Ostalecki C, Gläsner J, et al. (May 2016). "CD83 Modulates B Cell Activation and Germinal Center Responses". Journal of Immunology. 196 (9). Baltimore: 3581–3594. doi:10.4049/jimmunol.1502163. PMID 26983787.
Royzman D, Peckert-Maier K, Stich L, König C, Wild AB, Tauchi M, et al. (2022). "Soluble CD83 improves and accelerates wound healing by the induction of pro-resolving macrophages". Frontiers in Immunology. 13 1012647. doi:10.3389/fimmu.2022.1012647. PMC 9564224. PMID 36248909.
Peckert-Maier K, Wild AB, Sprißler L, Fuchs M, Beck P, Auger JP, et al. (2023). "Soluble CD83 modulates human-monocyte-derived macrophages toward alternative phenotype, function, and metabolism". Frontiers in Immunology. 14 1293828. doi:10.3389/fimmu.2023.1293828. PMC 10755915. PMID 38162675.
Wan S, Li Y, Liu X, Song X (July 2026). "Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation". The British Journal of Dermatology ljag274. doi:10.1093/bjd/ljag274. PMID 42397957.
Royzman D, Steinkasserer A (August 2026). "Expanding the therapeutic landscape of sCD83 in hair disorders". The British Journal of Dermatology ljag328. doi:10.1093/bjd/ljag328. PMID 42570012.

ensembl.org (Global: 630^th place; English: 326^th place)

may2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000112149 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000015396 – Ensembl, May 2017

mallia.com (Global: low place; English: low place)

"Our Science: Therapeutics". Mallia Therapeutics. Retrieved 7 August 2026.

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Prechtel AT, Steinkasserer A (May 2007). "CD83: an update on functions and prospects of the maturation marker of dendritic cells". Archives of Dermatological Research. 299 (2): 59–69. doi:10.1007/s00403-007-0743-z. PMID 17334966.
Grosche L, Knippertz I, König C, Royzman D, Wild AB, Zinser E, et al. (2020). "The CD83 Molecule - An Important Immune Checkpoint". Frontiers in Immunology. 11 721. doi:10.3389/fimmu.2020.00721. PMC 7181454. PMID 32362900.
Berchtold S, Jones T, Mühl-Zürbes P, Sheer D, Schuler G, Steinkasserer A (March 1999). "The human dendritic cell marker CD83 maps to chromosome 6p23". Annals of Human Genetics. 63 (Pt 2): 181–183. doi:10.1046/j.1469-1809.1999.6320181.x. PMID 10738529. S2CID 25338621.
Horvatinovich JM, Grogan EW, Norris M, Steinkasserer A, Lemos H, Mellor AL, et al. (March 2017). "Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14⁺ Monocytes". Journal of Immunology. 198 (6). Baltimore: 2286–2301. doi:10.4049/jimmunol.1600802. PMC 5340622. PMID 28193829.
Heilingloh CS, Klingl S, Egerer-Sieber C, Schmid B, Weiler S, Mühl-Zürbes P, et al. (April 2017). "Crystal Structure of the Extracellular Domain of the Human Dendritic Cell Surface Marker CD83". Journal of Molecular Biology. 429 (8): 1227–1243. doi:10.1016/j.jmb.2017.03.009. PMID 28315353.
Twist CJ, Beier DR, Disteche CM, Edelhoff S, Tedder TF (1998). "The mouse Cd83 gene: structure, domain organization, and chromosome localization". Immunogenetics. 48 (6): 383–393. doi:10.1007/s002510050449. PMID 9799334. S2CID 19869850.
Stein MF, Lang S, Winkler TH, Deinzer A, Erber S, Nettelbeck DM, et al. (April 2013). "Multiple interferon regulatory factor and NF-κB sites cooperate in mediating cell-type- and maturation-specific activation of the human CD83 promoter in dendritic cells". Molecular and Cellular Biology. 33 (7): 1331–1344. doi:10.1128/MCB.01051-12. PMC 3624272. PMID 23339870.
Michalski J, Deinzer A, Stich L, Zinser E, Steinkasserer A, Knippertz I (July 2020). "Quercetin induces an immunoregulatory phenotype in maturing human dendritic cells". Immunobiology. 225 (4) 151929. doi:10.1016/j.imbio.2020.151929. PMID 32115260.
Breloer M, Fleischer B (April 2008). "CD83 regulates lymphocyte maturation, activation and homeostasis". Trends in Immunology. 29 (4): 186–194. doi:10.1016/j.it.2008.01.009. PMID 18329338.
von Rohrscheidt J, Petrozziello E, Nedjic J, Federle C, Krzyzak L, Ploegh HL, et al. (August 2016). "Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83". The Journal of Experimental Medicine. 213 (9): 1685–1694. doi:10.1084/jem.20160316. PMC 4995086. PMID 27503071.
Cramer SO, Trumpfheller C, Mehlhoop U, Moré S, Fleischer B, von Bonin A (September 2000). "Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells". International Immunology. 12 (9): 1347–1351. doi:10.1093/intimm/12.9.1347. PMID 10967030.
Lechmann M, Krooshoop DJ, Dudziak D, Kremmer E, Kuhnt C, Figdor CG, et al. (December 2001). "The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells". The Journal of Experimental Medicine. 194 (12): 1813–1821. doi:10.1084/jem.194.12.1813. PMC 2193561. PMID 11748282.
Hirano N, Butler MO, Xia Z, Ansén S, von Bergwelt-Baildon MS, Neuberg D, et al. (February 2006). "Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity". Blood. 107 (4): 1528–1536. doi:10.1182/blood-2005-05-2073. PMC 1895420. PMID 16239433.
Bates JM, Flanagan K, Mo L, Ota N, Ding J, Ho S, et al. (March 2015). "Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis". Mucosal Immunology. 8 (2): 414–428. doi:10.1038/mi.2014.79. PMC 4326976. PMID 25204675.
Sinner P, Peckert-Maier K, Mohammadian H, Kuhnt C, Draßner C, Panagiotakopoulou V, et al. (August 2023). "Microglial expression of CD83 governs cellular activation and restrains neuroinflammation in experimental autoimmune encephalomyelitis". Nature Communications. 14 (1) 4601. doi:10.1038/s41467-023-40370-2. PMC 10393859. PMID 37528070.
Wu YJ, Song YN, Geng XR, Ma F, Mo LH, Zhang XW, et al. (2020). "Soluble CD83 alleviates experimental allergic rhinitis through modulating antigen-specific Th2 cell property". International Journal of Biological Sciences. 16 (2): 216–227. doi:10.7150/ijbs.38722. PMC 6949156. PMID 31929750.
Fujimoto Y, Tu L, Miller AS, Bock C, Fujimoto M, Doyle C, et al. (March 2002). "CD83 expression influences CD4+ T cell development in the thymus". Cell. 108 (6): 755–767. doi:10.1016/S0092-8674(02)00673-6. PMID 11955430.
Doebbeler M, Koenig C, Krzyzak L, Seitz C, Wild A, Ulas T, et al. (June 2018). "CD83 expression is essential for Treg cell differentiation and stability". JCI Insight. 3 (11) e99712. doi:10.1172/jci.insight.99712. PMC 6124443. PMID 29875316.
Maitra U, Davis S, Reilly CM, Li L (May 2009). "Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1". Journal of Immunology. 182 (9). Baltimore: 5763–5769. doi:10.4049/jimmunol.0900124. PMC 4773027. PMID 19380824.
Wild AB, Krzyzak L, Peckert K, Stich L, Kuhnt C, Butterhof A, et al. (October 2019). "CD83 orchestrates immunity toward self and non-self in dendritic cells". JCI Insight. 4 (20) e126246. doi:10.1172/jci.insight.126246. PMC 6824314. PMID 31527313.
Kretschmer B, Kühl S, Fleischer B, Breloer M (May 2011). "Activated T cells induce rapid CD83 expression on B cells by engagement of CD40". Immunology Letters. 136 (2): 221–227. doi:10.1016/j.imlet.2011.01.013. PMID 21277328.
Krzyzak L, Seitz C, Urbat A, Hutzler S, Ostalecki C, Gläsner J, et al. (May 2016). "CD83 Modulates B Cell Activation and Germinal Center Responses". Journal of Immunology. 196 (9). Baltimore: 3581–3594. doi:10.4049/jimmunol.1502163. PMID 26983787.
Royzman D, Peckert-Maier K, Stich L, König C, Wild AB, Tauchi M, et al. (2022). "Soluble CD83 improves and accelerates wound healing by the induction of pro-resolving macrophages". Frontiers in Immunology. 13 1012647. doi:10.3389/fimmu.2022.1012647. PMC 9564224. PMID 36248909.
Peckert-Maier K, Wild AB, Sprißler L, Fuchs M, Beck P, Auger JP, et al. (2023). "Soluble CD83 modulates human-monocyte-derived macrophages toward alternative phenotype, function, and metabolism". Frontiers in Immunology. 14 1293828. doi:10.3389/fimmu.2023.1293828. PMC 10755915. PMID 38162675.
Wan S, Li Y, Liu X, Song X (July 2026). "Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation". The British Journal of Dermatology ljag274. doi:10.1093/bjd/ljag274. PMID 42397957.
Royzman D, Steinkasserer A (August 2026). "Expanding the therapeutic landscape of sCD83 in hair disorders". The British Journal of Dermatology ljag328. doi:10.1093/bjd/ljag328. PMID 42570012.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: CD83 CD83 molecule". National Center for Biotechnology Information.
Grosche L, Knippertz I, König C, Royzman D, Wild AB, Zinser E, et al. (2020). "The CD83 Molecule - An Important Immune Checkpoint". Frontiers in Immunology. 11 721. doi:10.3389/fimmu.2020.00721. PMC 7181454. PMID 32362900.
Horvatinovich JM, Grogan EW, Norris M, Steinkasserer A, Lemos H, Mellor AL, et al. (March 2017). "Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14⁺ Monocytes". Journal of Immunology. 198 (6). Baltimore: 2286–2301. doi:10.4049/jimmunol.1600802. PMC 5340622. PMID 28193829.
Stein MF, Lang S, Winkler TH, Deinzer A, Erber S, Nettelbeck DM, et al. (April 2013). "Multiple interferon regulatory factor and NF-κB sites cooperate in mediating cell-type- and maturation-specific activation of the human CD83 promoter in dendritic cells". Molecular and Cellular Biology. 33 (7): 1331–1344. doi:10.1128/MCB.01051-12. PMC 3624272. PMID 23339870.
von Rohrscheidt J, Petrozziello E, Nedjic J, Federle C, Krzyzak L, Ploegh HL, et al. (August 2016). "Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83". The Journal of Experimental Medicine. 213 (9): 1685–1694. doi:10.1084/jem.20160316. PMC 4995086. PMID 27503071.
Lechmann M, Krooshoop DJ, Dudziak D, Kremmer E, Kuhnt C, Figdor CG, et al. (December 2001). "The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells". The Journal of Experimental Medicine. 194 (12): 1813–1821. doi:10.1084/jem.194.12.1813. PMC 2193561. PMID 11748282.
Hirano N, Butler MO, Xia Z, Ansén S, von Bergwelt-Baildon MS, Neuberg D, et al. (February 2006). "Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity". Blood. 107 (4): 1528–1536. doi:10.1182/blood-2005-05-2073. PMC 1895420. PMID 16239433.
Bates JM, Flanagan K, Mo L, Ota N, Ding J, Ho S, et al. (March 2015). "Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis". Mucosal Immunology. 8 (2): 414–428. doi:10.1038/mi.2014.79. PMC 4326976. PMID 25204675.
Sinner P, Peckert-Maier K, Mohammadian H, Kuhnt C, Draßner C, Panagiotakopoulou V, et al. (August 2023). "Microglial expression of CD83 governs cellular activation and restrains neuroinflammation in experimental autoimmune encephalomyelitis". Nature Communications. 14 (1) 4601. doi:10.1038/s41467-023-40370-2. PMC 10393859. PMID 37528070.
Wu YJ, Song YN, Geng XR, Ma F, Mo LH, Zhang XW, et al. (2020). "Soluble CD83 alleviates experimental allergic rhinitis through modulating antigen-specific Th2 cell property". International Journal of Biological Sciences. 16 (2): 216–227. doi:10.7150/ijbs.38722. PMC 6949156. PMID 31929750.
Doebbeler M, Koenig C, Krzyzak L, Seitz C, Wild A, Ulas T, et al. (June 2018). "CD83 expression is essential for Treg cell differentiation and stability". JCI Insight. 3 (11) e99712. doi:10.1172/jci.insight.99712. PMC 6124443. PMID 29875316.
Maitra U, Davis S, Reilly CM, Li L (May 2009). "Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1". Journal of Immunology. 182 (9). Baltimore: 5763–5769. doi:10.4049/jimmunol.0900124. PMC 4773027. PMID 19380824.
Wild AB, Krzyzak L, Peckert K, Stich L, Kuhnt C, Butterhof A, et al. (October 2019). "CD83 orchestrates immunity toward self and non-self in dendritic cells". JCI Insight. 4 (20) e126246. doi:10.1172/jci.insight.126246. PMC 6824314. PMID 31527313.
Royzman D, Peckert-Maier K, Stich L, König C, Wild AB, Tauchi M, et al. (2022). "Soluble CD83 improves and accelerates wound healing by the induction of pro-resolving macrophages". Frontiers in Immunology. 13 1012647. doi:10.3389/fimmu.2022.1012647. PMC 9564224. PMID 36248909.
Peckert-Maier K, Wild AB, Sprißler L, Fuchs M, Beck P, Auger JP, et al. (2023). "Soluble CD83 modulates human-monocyte-derived macrophages toward alternative phenotype, function, and metabolism". Frontiers in Immunology. 14 1293828. doi:10.3389/fimmu.2023.1293828. PMC 10755915. PMID 38162675.

patents.google.com (Global: 1,154^th place; English: 606^th place)

EP patent 4135745, Steinkasserer A, Zinser E, Royzman D, "Scd83 for Wound Healing, Hair Growth, and Skin and Hair Care", published 2023-02-22, issued 2025-05-07, assigned to Friedrich Alexander Universitaet Erlangen Nuernberg

semanticscholar.org (Global: 15^th place; English: 8^th place)

api.semanticscholar.org

Berchtold S, Jones T, Mühl-Zürbes P, Sheer D, Schuler G, Steinkasserer A (March 1999). "The human dendritic cell marker CD83 maps to chromosome 6p23". Annals of Human Genetics. 63 (Pt 2): 181–183. doi:10.1046/j.1469-1809.1999.6320181.x. PMID 10738529. S2CID 25338621.
Twist CJ, Beier DR, Disteche CM, Edelhoff S, Tedder TF (1998). "The mouse Cd83 gene: structure, domain organization, and chromosome localization". Immunogenetics. 48 (6): 383–393. doi:10.1007/s002510050449. PMID 9799334. S2CID 19869850.

CD83 (English Wikipedia)

doi.org (Global: 2nd place; English: 2nd place)

ensembl.org (Global: 630th place; English: 326th place)